BIOS Advisors GP, LLC

10% OwnerLantern Pharma Inc. (LTRN) · full profile →Form 4 · filed May 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$168K
Net Open-Market Flow
-$168K
Transactions
15
15 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2025Sell(S)6K$3.03$19K355K
May 29, 2025Sell(S)961$3.03$3K55K
May 29, 2025Sell(S)4K$3.03$11K207K
May 29, 2025Sell(S)7K$3.03$22K409K
May 29, 2025Sell(S)2K$3.03$7K125K
May 28, 2025Sell(S)2K$2.87$5K128K
May 28, 2025Sell(S)5K$2.87$15K416K
May 28, 2025Sell(S)714$2.87$2K56K
May 28, 2025Sell(S)5K$2.87$13K361K
May 28, 2025Sell(S)3K$2.87$8K211K
May 27, 2025Sell(S)4K$3.05$12K214K
May 27, 2025Sell(S)6K$3.05$20K365K
May 27, 2025Sell(S)2K$3.05$7K129K
May 27, 2025Sell(S)1K$3.05$3K56K
May 27, 2025Sell(S)7K$3.05$23K422K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-054422) within minutes of acceptance. Every field above traces to the original document. Verify it directly: